ArticleTherapeutic advances in chronic disease2022

Sodium-glucose cotransporter 2 inhibitors and neurological disorders: a scoping review.

Thahesh Tharmaraja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.